Showing codes 0078-0951-66 Tasigna — 0078-1070-96 Cosentyx
0078-0951-66 - Tasigna
Firm: Novartis Pharmaceuticals Corporation
Package Description: 120 CAPSULE in 1 BOTTLE, PLASTIC (0078-0951-66)
Usage type: ORAL
HTML TXT
0078-0953-25 - Tobradex
Firm: Novartis Pharmaceuticals Corporation
Package Description: 5 mL in 1 BOTTLE (0078-0953-25)
Usage type: OPHTHALMIC
HTML TXT
0078-0953-26 - Tobradex
Firm: Novartis Pharmaceuticals Corporation
Package Description: 10 mL in 1 BOTTLE (0078-0953-26)
Usage type: OPHTHALMIC
HTML TXT
0078-0953-40 - Tobradex
Firm: Novartis Pharmaceuticals Corporation
Package Description: 2.5 mL in 1 BOTTLE (0078-0953-40)
Usage type: OPHTHALMIC
HTML TXT
0078-0958-19 - Kymriah
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 INJECTION, SUSPENSION in 1 BAG (0078-0958-19)
Usage type: INTRAVENOUS
HTML TXT
0078-0965-89 - Gilenya
Firm: Novartis Pharmaceuticals Corporation
Package Description: 7 CAPSULE in 1 CARTON (0078-0965-89)
Usage type: ORAL
HTML TXT
0078-0972-61 - Promacta
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 CARTON in 1 KIT (0078-0972-61) / 30 PACKET in 1 CARTON (0078-0972-23) / 1 POWDER, FOR SUSPENSION in 1 PACKET (0078-0972-19)
Usage type: ORAL
HTML TXT
0078-0979-12 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 12 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-12)
Usage type: ORAL
HTML TXT
0078-0979-50 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-50)
Usage type: ORAL
HTML TXT
0078-0979-89 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 7 TABLET, FILM COATED in 1 BLISTER PACK (0078-0979-89)
Usage type: ORAL
HTML TXT
0078-0979-92 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 28 TABLET, FILM COATED in 1 BOTTLE (0078-0979-92)
Usage type: ORAL
HTML TXT
0078-0986-15 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0078-0986-15)
Usage type: ORAL
HTML TXT
0078-0986-45 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 15 TABLET, FILM COATED in 1 BOTTLE (0078-0986-45)
Usage type: ORAL
HTML TXT
0078-0986-93 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0078-0986-93)
Usage type: ORAL
HTML TXT
0078-0986-94 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 15 TABLET, FILM COATED in 1 BOTTLE (0078-0986-94)
Usage type: ORAL
HTML TXT
0078-1000-60 - Leqvio
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1000-60) / 1.5 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1000-98 - Leqvio
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1000-98) / 1.5 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1007-68 - Kesimpta
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1007-68) / .4 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1007-98 - Kesimpta
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1007-98) / .4 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1014-15 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0078-1014-15)
Usage type: ORAL
HTML TXT
0078-1014-93 - Mayzent
Firm: Novartis Pharmaceuticals Corporation
Package Description: 30 TABLET, FILM COATED in 1 BOTTLE (0078-1014-93)
Usage type: ORAL
HTML TXT
0078-1021-84 - Vijoice
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 BLISTER PACK in 1 CARTON (0078-1021-84) / 28 TABLET in 1 BLISTER PACK (0078-1021-51)
Usage type: ORAL
HTML TXT
0078-1021-91 - Vijoice
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 BLISTER PACK in 1 CARTON (0078-1021-91) / 28 TABLET in 1 BLISTER PACK (0078-1021-90)
Usage type: ORAL
HTML TXT
0078-1028-84 - Vijoice
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 BLISTER PACK in 1 CARTON (0078-1028-84) / 28 TABLET in 1 BLISTER PACK (0078-1028-51)
Usage type: ORAL
HTML TXT
0078-1028-91 - Vijoice
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 BLISTER PACK in 1 CARTON (0078-1028-91) / 28 TABLET in 1 BLISTER PACK (0078-1028-90)
Usage type: ORAL
HTML TXT
0078-1035-02 - Vijoice
Firm: Novartis Pharmaceuticals Corporation
Package Description: 2 BLISTER PACK in 1 CARTON (0078-1035-02) / 1 KIT in 1 BLISTER PACK (0078-1035-61)
HTML TXT
0078-1035-92 - Vijoice
Firm: Novartis Pharmaceuticals Corporation
Package Description: 2 BLISTER PACK in 1 CARTON (0078-1035-92) / 1 KIT in 1 BLISTER PACK (0078-1035-94)
HTML TXT
0078-1056-97 - Cosentyx
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1056-97) / .5 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1056-99 - Cosentyx
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1056-99) / .5 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1070-68 - Cosentyx
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1070-68) / 2 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT
0078-1070-96 - Cosentyx
Firm: Novartis Pharmaceuticals Corporation
Package Description: 1 SYRINGE, GLASS in 1 CARTON (0078-1070-96) / 2 mL in 1 SYRINGE, GLASS
Usage type: SUBCUTANEOUS
HTML TXT